June 10 (Reuters) - A top Eli Lilly ( LLY ) executive said on Monday that more patients are paying the full list price of its obesity drug Zepbound than those who had paid for its predecessor Mounjaro. Patrik Jonsson, President of Lilly Diabetes and Obesity, speaking at a Goldman Sachs healthcare conference, said a mid-single digit percentage of patients...

04:35 PM EDT, 06/10/2024 (MT Newswires) -- Array Technologies ( ARRY ) said late Monday that Kurt Wood will step down as chief financial officer on June 30 to pursue other business interests. Wood will remain with the solar-tracking equipment company as a consultant through the end of September to assist with the transition. The company said it has begun...

04:31 PM EDT, 06/10/2024 (MT Newswires) -- James A Faulconbridge, Director, on June 06, 2024, executed a purchase for 3,300 shares in Hawkins (HWKN) for $288,907. Following the Form 4 filing with the SEC, Faulconbridge has control over a total of 42,017 shares of the company, with 42,017 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/46250/000141588924016220/xslF345X03/form4-06102024_080621.xml ...

04:31 PM EDT, 06/10/2024 (MT Newswires) -- Stephen Neeleman, Director, Founder and Vice Chairman, on June 06, 2024, sold 9,564 shares in Healthequity ( HQY ) for $813,302. Following the Form 4 filing with the SEC, Neeleman has control over a total of 852,750 shares of the company, with 90,515 shares held directly and 762,235 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1428336/000141588924016224/xslF345X03/form4-06102024_080647.xml...